Financials

News Discussions Technicals

ZYBT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Zhengye Biotechnology Holding Limited operating, investing, and financing activities

ZYBT free cash flow for H2 24 is 2.03 M USD. For 2024, ZYBT free cash flow was 3.82 M USD and operating cash flow was 5.7 M USD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—